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BY-NC-ND license (http://creativecomBackground/purpose: Cases of type 1 diabetes mellitus in children aged younger than 6 years
in Taiwan has increased in the past 10 years. This retrospective study aimed to review the
management experience of such patients in a single center.
Methods: From January 2004 to June 2015, 52 newly diagnosed diabetic children younger than
6 years who had regular follow-up for > 1 year were enrolled, as well as 94 older diabetic
children for comparison. Their medical records were thoroughly reviewed.
Results: The most common symptoms and signs were polyuria, polydipsia, dry lips, weight loss,
and nocturia. Among the children younger than 6 years, 87% had ketoacidosis upon diagno-
sisdsignificantly higher than that of the older age groupdand 88% had at least one islet
cell autoantibody detected. Their serum C-peptide levels were significantly lower and the
frequency of insulin autoantibodies detected was significantly higher compared with the older
age group (37% vs. 10%). The remission rate of the young diabetic patients was significantly
lower than that of the older age group (40% vs. 59%), but there was no difference in time of
onset and duration of remission between the two groups.
Conclusion: Autoimmune destruction of pancreatic b-cells is an important cause of type 1 dia-
betes mellitus in Taiwanese children aged younger than 6 years. These patients usually have a
low insulin reserve and severe ketoacidosis upon diagnosis. A high index of suspicion in the
presence of classic symptoms of diabetes in young children is important to prevent complica-
tions.
Copyright ª 2016, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).ave no conflicts of interest relevant to this article.
t of Pediatrics, National Taiwan University Hospital and College of Medicine, National Taiwan
th Road, Taipei 10002, Taiwan.
u.tw (W.-Y. Tsai).
en Y-C, et al., Clinical characteristics of type 1 diabetes mellitus in Taiwanese children aged younger
perience, Journal of the Formosan Medical Association (2016), http://dx.doi.org/10.1016/
6.07.005
n Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC
mons.org/licenses/by-nc-nd/4.0/).
2 Y.-C. Chen et al.
+ MODELIntroduction
The most common type of diabetes mellitus in children is
type 1 diabetes mellitus (T1DM), which in most cases is
caused by the autoimmune destruction of pancreatic b-
cells.1 Although the incidence of T1DM in Taiwanese chil-
dren is much lower than that among Caucasian children,2
the underlying mechanisms are the same.3 Some newly
diagnosed T1DM patients experience a period of good blood
glucose control, with a reduction of daily insulin dose after
the start of insulin therapy. This period is known as the
“honeymoon period.” The underlying mechanism of the
honeymoon period remains unknown but a transient
restoration of residual pancreatic b-cell function in an
otherwise insulin-sensitive environment has been pro-
posed.4,5 Few cases remain symptom-free without any in-
sulin injection (complete remission) and most patients still
require small amounts of insulin to maintain near normal
blood glucose levels (partial remission) during the honey-
moon period.4,6 This period has since become the potential
target window for immunomodulation therapy to preserve
residual pancreatic b-cell mass.7 However, there is a
paucity of updated data in Taiwanese children with T1DM.
In the past few decades, the annual incidence of T1DM in
children worldwide, including Taiwan, has been
increasing.2,8e11 Cases of T1DM in younger children is
increasing but few reports present clinical data.12 Thus,
this retrospective study aimed to assess a single-center
experience in the management of T1DM in Taiwanese
children aged younger than 6 years.
Subjects and methods
From January 2004 to June 2015, the medical record of all
children aged  18 years with new onset of T1DM diagnosed
at the Department of Pediatrics of National Taiwan Uni-
versity Hospital were reviewed. Among them, 52 children
aged younger than 6 years, who had detailed data for
analysis, and who had been followed-up at the Pediatric
Endocrine Clinic of National Taiwan University Hospital for
longer than 1 year were enrolled in this study. In the same
period, 94 children aged 6e18 years with new onset of
T1DM were also enrolled for comparison.
The diagnosis of T1DM was made according to the 1997
Criteria of the Expert Committee.13 Diabetic ketoacidosis
(DKA) was diagnosed in the presence of pH < 7.3, hyper-
glycemia, ketonemia and/or ketonuria, and serum bicar-
bonate < 15mM.
Complete history, including family history, and physical
examination were recorded for all patients with T1DM upon
diagnosis. Laboratory tests, including blood glucose, gly-
cated hemoglobin (HbA1c), ketone bodies, serum sodium,
potassium, chloride, blood gas analysis, antiglutamic acid
decarboxylase 65 autoantibodies (GADA), anti-insulinoma
antigen-2 autoantibodies (IA-2A), insulin autoantibodies
(IAA), and C-peptide levels at glucagon test were also
determined upon diagnosis. A 6-minute glucagon test was
performed according to the protocol in literature,14 whereas
C-peptide levels were measured using commercially avail-
able kits. Islet-cell autoantibodies, including GADA, IA-2A,
and IAA were measured as previously reported.3Please cite this article in press as: Chen Y-C, et al., Clinical characteris
than 6 years: A single-center experience, Journal of the Form
j.jfma.2016.07.005All of the patients were regularly followed up once every
3 months. The patients’ height, weight, daily insulin doses,
blood sugar, and HbA1c levels were checked upon each
visit. Remission was defined according to the criteria re-
ported by Mortensen et al.15
Statistical analysis
All data were presented as percentage or as
mean  standard deviation. Pearson’s c2 test was used to
compare categorical data, whereas the ManneWhitney U-
test was used to compare numerical data. One-way analysis
of variance was used for the analysis of the remission
period in both age groups. Statistical significance was set at
p < 0.05. All statistical analyses were performed using the
SPSS 20.0 Package for Windows (SPSS Inc, Chicago, IL, USA).
Results
The study enrolled 52 children aged younger than 6 years,
including 26 boys and 26 girls. Their age upon diagnosis
was 4.3  1.6 years. One patient had a mother and two
patients had siblings with T1DM. However, of the 94 chil-
dren aged 6e18 years enrolled for comparison, there were
40 boys and 54 girls. Their age upon diagnosis was
10.8  2.6 years.
The most common initial clinical manifestations in chil-
dren aged < 6 years were polyuria (96%), polydipsia (92%),
dry lips (81%), body weight loss (79%), nocturia (77%), pre-
vious history of respiratory tract infection (48%), dyspnea
(46%), sunken eyeballs (24%), and polyphagia (21%). There
were no significant differences in most of the clinical
findings between children aged < 6 years (younger age
group) and those aged 6e18 years (older age group).
However, there were significant differences in dry lips (81%
vs. 63%, p < 0.05), frequency of previous respiratory tract
infections (48% vs. 22%, p < 0.005), and dyspnea (46% vs.
29%, p < 0.05). In the younger age group, 45 (87%) had DKA
as the initial manifestation. This was significantly higher
than the 55% in the older age group (p < 0.001).
Plasma glucose level was significantly higher and plasma
HbA1c, pCO2, bicarbonate, and sodium levels were signifi-
cantly lower in the younger age group than in the older age
group (Table 1). In terms of C-peptide levels during the
glucagon test, both C-peptide levels at baseline and at 6
minutes after glucagon stimulation were significantly lower
in the younger age group than in the older age group.
Only 12% in the younger age group and 7% in the older
age group did not have any detectable islet cell autoan-
tibodies (Table 1). The frequency of islet cell autoanti-
bodies detected in the younger age group was 62% in GADA
and 69% in IA-2A. These were not significantly different
from those detected in the older age group. However, 37%
of patients in the younger age group had IAA detected.
This was significantly higher than the 10% of the older age
group.
In the younger age group, remission occurred in 21 pa-
tients (40%), being complete in two (4%). However, 55
children (59%) in the older age group achieved remission,
being completed in 11 (12%; Table 2). The remission rate of
the younger age group was significantly lower.tics of type 1 diabetes mellitus in Taiwanese children aged younger
osan Medical Association (2016), http://dx.doi.org/10.1016/
Table 1 Laboratory data in children with type 1 diabetes
mellitus.
< 6 y
(n Z 52)
6e18 y
(n Z 94)
p
Glucose (mg/dL) 521  156 451  210 0.006
HbA1c (%) 12.3  2.1 13.9  2.4 <0.001
Ketone (mM) 4.1  1.4 3.8  2.0 0.552
pH 7.23  0.16 7.27  0.14 0.314
pCO2 (mmHg) 20.5  8.8 29.7  13.0 <0.001
HCO3
 (mM) 10.3  7.5 15.1  8.4 0.001
Na (mM) 131.1  5.6 133.5  4.4 0.002
K (mM) 4.3  0.7 4.4  0.7 0.923
Cl (mM) 101.9  8.0 101.2  5.5 0.431
C-peptide (nmol/L)
Basal 0.12  0.13 0.18  0.09 <0.001
Postglucagon 0.16  0.08 0.32  0.22 <0.001
Islet cell autoantibodies
GADA positivity 32 (62%) 66 (70%) 0.285
IA-2A positivity 36 (69%) 75 (80%) 0.153
IAA positivity 19 (37%) 9 (10%) <0.001
None detected 6 (12%) 7 (7%) 0.406
GADA Z antiglutamic acid decarboxylase autoantibodies;
HbA1c Z glycated hemoglobin; IA-2A Z anti-insulinoma
antigen-2 autoantibodies; IAA Z anti-insulin autoantibodies.
Table 2 Natural course of remission in children with type
1 diabetes mellitus.
< 6 y 6e18 y
Total patients (N ) 52 94
Patients with remission (N ) 21 55 0.036
Onset of remission, n (%) 0.637
<3 mo 19 (90) 49 (89)
3e6 mo 2 (10) 4 (7)
6e9 mo 0 2 (4)
Duration of remission, n (%) 0.094
<3 mo 4 (19) 26 (47)
3e6 mo 2 (9) 7 (12)
6e9 mo 6 (29) 8 (15)
9e12 mo 5 (24) 1 (2)
>12 mo 4 (19) 13 (24)
T1DM in young Taiwanese children 3
+ MODELIn the younger age group, the proportion of boys (57% vs.
46%) and girls (43% vs. 54%) were comparable between the
remitter and the nonremitter (p Z 0.397). Most patients,
90% in the younger age group and 89% in the older age
group, had an onset of remission during the 1st 3 months
(Table 2), which was not statistically significant. Twelve
(57%) in the younger age group achieved remission < 9
months, whereas 59% in the older age group achieved
remission < 6 months. However, six out of 21 (19%) in the
younger age group and 13 out of 55 (24%) in older age group
achieved remission longer than 1 year. The difference was
not statistically significant.
Among patients in the younger age group, different
clinical and laboratory variables were compared between
patients with and without remission to determine the
associated factors. However, there were no associationsPlease cite this article in press as: Chen Y-C, et al., Clinical characteris
than 6 years: A single-center experience, Journal of the Form
j.jfma.2016.07.005among DKA at diagnosis, HbA1c levels at diagnosis, C-pep-
tide levels, and rate of remission.Discussion
In literature, 9% of young Caucasian children with T1DM
have a first degree family member with T1DM, with a pre-
dominance of fathers over mothers.16 However, in this
study, only one patient had a mother with T1DM. This may
be partially due to ethnic differences.
In both the younger and older age groups, the most
common symptoms noted upon diagnosis were polyuria,
polydipsia, body weight loss, and nocturia. However,
ketoacidosis, dry lips, and dyspnea are more common initial
clinical manifestations in the younger age group compared
with the older age group. Such findings may suggest that
patients aged < 6 years experience a more unstable
metabolic situation upon diagnosis than older patients.
In this study, serum C-peptide levels, both basal and
glucagon-stimulated, of patients younger than 6 years were
lower than those of older patients, implying that the
younger age group had less insulin reserve than older age
group. This is consistent with findings of our previous
report14 and other studies.17,18 The present study also
showed that the frequency of previous respiratory tract
infection in children younger than 6 years was higher than
that of the older age group, which is similar to the results of
another study.19
In this study,w87% of patients younger than 6 years had
ketoacidosis upon diagnosis. They also had higher blood
glucose levels, lower pCO2 levels, and lower bicarbonate
levels upon diagnosis than the older patients. Taken
together, these suggest that patients younger than 6 years
not only have a higher frequency, but also more severe
degrees of ketoacidosis than older patients. Thus, less in-
sulin reserve with stress related to viral infection may play
an important role in unstable situations of patients aged
< 6 years upon diagnosis.
The frequency of islet cell autoantibodies has been re-
ported to be significantly less in early-onset diabetes.19
However, in this study, 88% of diabetic patients aged
younger than 6 years had at least one autoantibody
detected. Their frequency of GADA and IA-2A positivity was
similar to those of the older age group, but their frequency
of IAA positivity was significantly higher, similar to findings
of our previous report3 and other studies.18 This may be
explained by the fact that IAA is the first detectable b-cell
autoantibody among high-risk prediabetic children and that
it disappears more rapidly than other autoantibodies.20,21
The present study confirms that autoimmune destruction
of pancreatic b-cell is an important cause of T1DM in
Taiwanese children younger than 6 years old.
This study also demonstrates a higher rate and severity
of DKA with lower HbA1c levels upon diagnosis of diabetic
children aged < 6 years. The results may suggest more
rapid and extensive pancreatic b-cell damage by an auto-
immune process, resulting in a more severe metabolic
decompensation at diagnosis, consistent with results of
previous reports.22
In newly-diagnosed type 1 diabetic children, there is
often a period of remission during the natural course of thetics of type 1 diabetes mellitus in Taiwanese children aged younger
osan Medical Association (2016), http://dx.doi.org/10.1016/
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maintain good metabolic control. Different criteria have
been used to define remission. Daily insulin requirement
alone or HbA1c alone has been used to define remission in
some studies,23e25 whereas other studies include daily in-
sulin requirements and HbA1c in defining remis-
sion.15,22,26,27 As remission defined by daily insulin
requirement alone or HbA1c tends to overestimate remis-
sion rates, insulin dose-adjusted A1c, proposed by Mor-
tensen et al15 to define remission, was used in the present
study. The reported remission rates vary between 25% and
100%, which partially reflects the different definitions used
and the difference in patients’ ages.23,24
In this study, the frequency of remission is 40% in the
younger age group, which is similar to a previous study
using the same definition for remission.27 The result is also
similar to other studies with different definitions for
remission.22,26 Although complete remission is rare in chil-
dren with T1DM,26,27 this study shows that complete
remission has occurred in 4% of patients younger than 6
years, as previously reported.28 Pecheur et al27 reported
that children younger than 4 years had similar remission
rates to older children. However, this study demonstrates
that children younger than 6 years have remission rates
lower than older children, confirming results of other re-
ports.22,26 This study also reveals that children younger
than 6 years were similar to the older age group with
regards to time of onset and duration of remission. The
result is consistent with the study reported by Pecheur
et al.27
In addition, DKA at diagnosis has been associated with a
lower remission rate and shorter duration of remis-
sion.22,26,27 However, there has been no association be-
tween DKA and remission rate. In this study, most patients
younger than 6 years had DKA at diagnosis, which might
disguise a potential influence of DKA on remission. Lower
HbA1c levels at diagnosis have also been associated with
higher remission rate27 and C-peptide levels have been
correlated with remission rate.6,27,29 However, in this
study, there is no such association. Thus, further study is
warranted to clarify the discrepancy.
In conclusion, most Taiwanese children younger than
6 years old have T1DM due to autoimmune destruction of
pancreatic b-cells. Most of them have severe ketoacidosis
as the initial manifestation. Primary care physicians should
have a high index of suspicion when managing young chil-
dren with classic symptoms and signs of diabetes mellitus in
the presence of a respiratory tract infection for proper
timely intervention.References
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